Open House - Global Healthcare 2022: Biondvax | Edison Group
Biondvax is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses.
-
Josh Phillipson, Director of Business Development and Investor Relations, Biondvax
Mr. Joshua E. Phillipson has led business development activities including marketing, investor and public relations at BiondVax since 2015. Prior to joining BiondVax, Mr. Phillipson was Marketing Manager at BioData Ltd. Earlier in his career, he served as a business management consultant with Accenture in various industries including pharmaceutical, and as partnerships coordinator for the Canada-Israel Industrial R&D Foundation. Mr. Phillipson earned an Honours BSc. from the University of Toronto and an MBA from the Ben-Gurion University of the Negev.
